Jan Korabecny

National Institute of Mental Health

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (22)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (16)

Tomáš Zárybnický

University of Helsinki

FINLAND

View details

Lucie Cahlikova

Charles University

CZECH REPUBLIC

View details

Radomír Jůza

National Institute of Mental Health

CZECH REPUBLIC

View details

Monika Schmidt

Assistant professor

University of Hradec Kralove, Faculty of Science

CZECH REPUBLIC

View details

Jana Maříková

assistant professor

Charles University

CZECH REPUBLIC

View details

Lenka Pulkrabkova

Fakultní Nemocnice Hradec Králové

CZECH REPUBLIC

View details

Kateřina Breiterová

postdoc, assistant professor

Charles University, Faculty of Pharmacy in Hradec Kralove

CZECH REPUBLIC

View details

Jaroslav Roh

Associate Professor

Charles University, Faculty of Pharmacy in Hradec Kralove

CZECH REPUBLIC

View details

Rudolf Vrabec

Assistant professor

Charles University, Faculty of Pharmacy in Hradec Kralove

CZECH REPUBLIC

View details

Ondrej Benek

University Hospital Hradec Králové

CZECH REPUBLIC

View details

Jaroslav Pejchal

Chief of toxicology group/associate professor

CZECH REPUBLIC

View details

Martina Řezáčová

CZECH REPUBLIC

View details

Ondrej Soukup

University Hospital Hradec Králové

CZECH REPUBLIC

View details

Mária Kožurková

SLOVAKIA

View details

Kamil Musilek

CZECH REPUBLIC

View details

Martina Hrabinova

University of Defence

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jan Korabecny

Research Interests

Contact this professor

Articles (22)

Revolutionizing tuberculosis treatment: Breakthroughs, challenges, and hope on the horizon

Prophylaxis by a reversible cholinesterase inhibitor and the NMDA receptor antagonist treatment as combinatorial countermeasure against nerve agent poisoning in mice model

Effect of hexyloxy position on antagonistic properties of KH-5 (1-{2-[4-(hexyloxy)benzoyloxy]ethyl}-1-methyl-1,2,3,6-tetrahydropyridin-1-ium iodide) at muscarinic acetylcholine receptors

Strategies for the treatment of acute myeloid leukemia with FLT3 mutations: a patent review

Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: Novel molecular approaches and therapeutic challenges

A-agents, misleadingly known as “Novichoks”: a narrative review

Structure-Guided Design of <i>N</i>-Methylpropargylamino-Quinazoline Derivatives as Multipotent Agents for the Treatment of Alzheimer’s Disease

Tacrine First-Phase Biotransformation and Associated Hepatotoxicity: A Possible Way to Avoid Quinone Methide Formation

IN SILICO LIBRARY SCREENING TO FIND NOVEL ANTICANCER AGENT WITH CHEMOSENSITIZING PROPERTIES: FOCUS ON TARGETING ATAXIA TELANGIECTASIA AND Rad3 RELATED KINASE

Neurotoxicity evoked by organophosphates and available countermeasures

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders

Pyrimidine derivatives with antitubercular activity

Alkaloids of Dicranostigma franchetianum (Papaveraceae) and Berberine Derivatives as a New Class of Antimycobacterial Agents

Chemical and Biological Threats, Hazard Potential and Countermeasures

Countermeasures in organophosphorus intoxication: pitfalls and prospects

Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies

Synthesis and In Vitro Evaluation of Novel Dopamine Receptor D<sub>2</sub> 3,4-dihydroquinolin-2(1<i>H</i>)-one Derivatives Related to Aripiprazole

Cholinesterase Research

Synthesis of New Biscoumarin Derivatives, In Vitro Cholinesterase Inhibition, Molecular Modelling and Antiproliferative Effect in A549 Human Lung Carcinoma Cells

A Perspective on Multi-target Drugs for Alzheimer’s Disease

Amaryllidaceae Alkaloids of Belladine-Type from <i>Narcissus pseudonarcissus</i> cv. Carlton as New Selective Inhibitors of Butyrylcholinesterase

Aromatic Esters of the Crinane Amaryllidaceae Alkaloid Ambelline as Selective Inhibitors of Butyrylcholinesterase

Collaborators (16)

Tomáš Zárybnický

Lucie Cahlikova

Radomír Jůza

Monika Schmidt

Jana Maříková

Lenka Pulkrabkova

Kateřina Breiterová

Jaroslav Roh

Rudolf Vrabec

Ondrej Benek

Jaroslav Pejchal

Martina Řezáčová

Ondrej Soukup

Mária Kožurková

Kamil Musilek

Martina Hrabinova

Make your next move.